DYD. Y. Yuriev

D. Y. Yuriev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


D. Y. Yuriev has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Innovative design of fluorescent PLGA–1,8-naphthalimide nanoparticles as multifunctional materials for next-generation nanotechnology and biomedicine

    by Yuriev Danil, Tkachenko Sergey, Ermolin Danila, Ivanov Ilya, Melnikov Pavel, Malinovskaya Julia, Ryabova Anastasia, Mishin Alexander, Perfilov Maxim, Ramil Khasbiullin, et al.

    Cellular imaging with PLGA nanoparticles functionalized with 1,8-naphthalimide dyes: photostable fluorescent probes with sustained emission and stable colloidal properties.


  • Open Access

    Continuous-flow synthesis of the naphthalimide derivatives for medical and engineering applications

    by Maxim Oshchepkov, Sergey Tkachenko, Konstantin Popov, Aleksey Semyonkin, Danil Yuriev, Inna Solovieva, Pavel Melnikov, Julia A. Malinovskaya, Alexander Oshchepkov


  • Open Access

    Bifunctional gallium cation chelators

    by A. G. Polivanova, I. N. Solovieva, D. O. Botev, D. Y. Yuriev, A. N. Mylnikova, M. S. Oshchepkov

    Objectives. The chemistry of 67Ga and 68Ga radionuclides plays a key role in nuclear medicine for applications in radiopharmaceuticals, in particular, in noninvasive in vivo molecular imaging techniques. The use of radiometals for labeling biomolecules typically requires the use of bifunctional chelators, which contain a functional group for covalent bonding with the targeting vector in addition to the polydentate fragment coordinating the metal. The aim of the present review article is to analyze the currently accumulated experimental material on the development and application of bifunctional chelators of gallium cations in medical research, as well as to identify the main requirements for the structure of the chelator and its complexes with 68Ga, which are used to create effective Gabased pharmaceutical preparations.Results. The review analyzed macrocyclic bifunctional chelators forming stable in vivo complexes with 68Ga and acyclic chelators, whose main advantage is faster complexation kinetics due to the short half-life of 68Ga. The advantages and disadvantages of both types of ligands were evaluated. In addition, a critical analysis of the binding constants and the conditions for the formation of complexes was presented. Examples of the influence of the geometry, lipophilicity, and total charge of the metal complex on the biodistribution of target radiopharmaceuticals were also given.Conclusions. Despite the progress made in the considered areas of bifunctional chelators, the problem of correlating the chemical structure of a metal-based radiopharmaceutical with its behavior in vivo remains important. Comparative studies of drugs having an identical targeting vector but containing different bifunctional chelating agents could help further elucidate the effectof metal chelate moiety on pharmacokinetics. In order to create effective bifunctional chelating agents, it is necessary to take into account such factors as the stability and inertness of the chelator and its complexes under physiological conditions, lipophilicity, complexation kinetics, chelation selectivity, combinatoriality of the basic structure, along with economic aspects, e.g., the availability of raw materials and the complexity of the synthesis scheme.